Valeant amends credit facility for second time in six months

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/13/2026

1. WDAY
2. AAPL
3. JNJ
4. AMAT
5. META
6. NVDA
7. NRIX
8. SPY
9. BAC
10. SUNS

Go back to Valeant amends credit facility for second time in six months

Valeant's (VRX) Amended Facility Expected, But Shares Remain Uninvestible - Piper

August 19, 2016 6:39 AM EDT

Piper Jaffray affirms Valeant Pharma (NYSE: VRX) with an Underweight rating and $22 price target following news that the company entered an amended credit facility.

Analyst David Amsellem commented today:

Valeant shares have been strong of late, ostensibly in anticipation of an amendment to the companys credit facility (which was announced on Thursday) that gives the company more breathing room as it looks to stabilize and turn around key segments and sell off non-core assets... More

RBC Capital Remains Sidelined as Valeant Pharma (VRX) Announces Credit Amendment

August 18, 2016 11:15 AM EDT

RBC Capital reiterated a Sector Perform rating and $36.00 price target on Valeant Pharmaceuticals (NYSE: VRX) following the company's announcement that is has agreed to amend terms with its lenders. This decision comes on the heels of VRX's Aug 12th announcement that the company would... More